Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $279.07 -1.19%
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
